Skip to main content
OpenTrials

Clinical trial condition

Non-small Cell Lung Cancer

Explore clinical trials studying Non-small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

1,335 public trials 328 recruiting studies
Refine in advanced search Browse all conditions

Non-small Cell Lung Cancer trial results

Recruiting

Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer

NCT05142189

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +19 more
Locations
  • University of Kentucky Chandler Medical Center Lexington, Kentucky, United States
  • Norton Cancer Institute Louisville, Kentucky, United States
  • Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
  • Ohio State University Columbus, Ohio, United States
View all 45 locations
View Trial Details
Recruiting

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

NCT06758401

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +12 more
Locations
  • Providence Medical Foundation Fullerton, California, United States
  • Providence St. Jude Medical Center Virginia K. Crosson Cancer Center and Infusion Center Fullerton, California, United States
  • St. Jude Heritage Medical Group - Fullerton Plaza Multi-Specialty Clinic (Pulmonary Function Test) Fullerton, California, United States
  • Intermountain Health Cancer Center Lutheran Hospital Golden, Colorado, United States
View all 372 locations
View Trial Details
Recruiting

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

NCT06767514

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Clinical Study Site Chandler, Arizona, United States
  • Clinical Study Site Phoenix, Arizona, United States
  • Clinical Study Site Hot Springs, Arkansas, United States
  • Clinical Study Sites Jonesboro, Arkansas, United States
View all 270 locations
View Trial Details
Recruiting

Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer

NCT06899126

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Alaska Oncology & Hematology, LLC Anchorage, Alaska, United States
  • Orange Coast Memorial Medical Center Fountain Valley Fountain Valley, California, United States
  • California Research Institute Los Angeles, California, United States
  • Los Angeles Cancer Network (LACN) Los Angeles, California, United States
View all 237 locations
View Trial Details
Recruiting

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

NCT06765109

Conditions
Anaplastic Lymphoma Kinase-positive, Bronchial Neoplasms, Carcinoma, Bronchogenic, +9 more
Locations
  • Palo Verde Hematology Oncology Glendale, Arizona, United States
  • Hoag Hospital Newport Beach Newport Beach, California, United States
  • University of California, Irvine Health Orange, California, United States
  • Rocky Mountain Cancer Centers Boulder, Colorado, United States
View all 157 locations
View Trial Details
Recruiting

A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)

NCT07190248

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Central Alabama Research ( Site 0108) Birmingham, Alabama, United States
  • University of Connecticut Health Center ( Site 0130) Farmington, Connecticut, United States
  • Stamford Hospital ( Site 0126) Stamford, Connecticut, United States
  • Mount Sinai Cancer Center ( Site 0137) Miami Beach, Florida, United States
View all 195 locations
View Trial Details
Recruiting

Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]

NCT06422143

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • CARTI Cancer Center ( Site 0006) Little Rock, Arkansas, United States
  • Roy and Patricia Disney Family Cancer Center - Providence Saint Joseph Medical Center ( Site 0122) Burbank, California, United States
  • Sharp Memorial Hospital ( Site 9544) San Diego, California, United States
  • Intermountain Health Cancer Center Lutheran Hospital ( Site 0119) Golden, Colorado, United States
View all 215 locations
View Trial Details
Recruiting

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

NCT06881784

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations
  • Alabama Oncology Birmingham, Alabama, United States
  • MemorialCare Long Beach Medical Center Long Beach, California, United States
  • Yale University, Smillow Cancer Center New Haven, Connecticut, United States
  • Florida Cancer Specialists & Research Institute - South Fort Myers, Florida, United States
View all 152 locations
View Trial Details

Related conditions